– Prove Your Product's Worth to Funders, Hospitals & Regulators
HTA That Bridges Clinical Value
Pricing Made Simple
In South Africa’s value-conscious market, HTA determines whether your innovation gets:
✔ Reimbursement approval from medical schemes
✔ Premium pricing recognition
We conduct full-spectrum HTAs that speak the language of:
Funder’s value assessment committees
Hospital procurement decision-makers
SAHPRA’s benefit-risk frameworks
Why Choose Our
HTA Optimization Services ?
Funder-Aligned Frameworks
Tailored to Funder's evidence requirements
Dual Clinical-Economic Focus
Simultaneously prove risk sharing initiatives and cost savings
Hospital Procurement Approval
Includes aspects such as length of stay , level of care ,level of acuity ,etc
Where Science Meets Reimbursement Strategy–
Empowering
Healthcare Through Smart Consulting Solutions
Our HTAs go beyond normal day to day practices to actively persuade:
Secure higher premium pricing
- Minimize patient Co-payment
We combine SA-specific cost data with global HTA methodologies.
High First-Time Approval Rate
Model Transparency (all assumptions documented)
Accuracy Rate on catalogue submissions
From Evidence to Market Access
Phase 1: Clinical Value Proposition
“Systematic review of:
Comparative effectiveness vs standard care
Clinical Dossier requirements
Phase 2: Economic Modeling
“Budget impact models showing:
Hospital savings (LOS, readmissions)
Break-even analyses
Phase 3: Submission & Negotiation
“Support during:
Funder review
PHG procurement decision making
Other Funding committees or societies
Help Centre.
Got questions?
We emphasize the impact of South African’s , burden of disease
We bridge gaps using:*
Society endorsement
Public Sector utilization
- Working with funders on risk sharing initiative’s
Funder stipulates 12 months waiting period until next submission
12-18 Months post-HTA submission to major schemes.